IT1270836B - Procedimento per la preparazione di rufloxacina e suoi sali - Google Patents

Procedimento per la preparazione di rufloxacina e suoi sali

Info

Publication number
IT1270836B
IT1270836B ITMI932286A ITMI932286A IT1270836B IT 1270836 B IT1270836 B IT 1270836B IT MI932286 A ITMI932286 A IT MI932286A IT MI932286 A ITMI932286 A IT MI932286A IT 1270836 B IT1270836 B IT 1270836B
Authority
IT
Italy
Prior art keywords
rufloxacin
salts
pct
preparation
formula
Prior art date
Application number
ITMI932286A
Other languages
English (en)
Inventor
Pietro Bellani
Original Assignee
Archimica Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Archimica Spa filed Critical Archimica Spa
Publication of ITMI932286A0 publication Critical patent/ITMI932286A0/it
Priority to ITMI932286A priority Critical patent/IT1270836B/it
Priority to EP94931550A priority patent/EP0725785B1/en
Priority to ES94931550T priority patent/ES2105780T3/es
Priority to AT94931550T priority patent/ATE155788T1/de
Priority to JP7512408A priority patent/JPH09504283A/ja
Priority to DK94931550.1T priority patent/DK0725785T3/da
Priority to PCT/EP1994/003512 priority patent/WO1995011907A1/en
Priority to US08/632,426 priority patent/US5731433A/en
Priority to DE69404476T priority patent/DE69404476T2/de
Publication of ITMI932286A1 publication Critical patent/ITMI932286A1/it
Application granted granted Critical
Publication of IT1270836B publication Critical patent/IT1270836B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06Peri-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
ITMI932286A 1993-10-27 1993-10-27 Procedimento per la preparazione di rufloxacina e suoi sali IT1270836B (it)

Priority Applications (9)

Application Number Priority Date Filing Date Title
ITMI932286A IT1270836B (it) 1993-10-27 1993-10-27 Procedimento per la preparazione di rufloxacina e suoi sali
JP7512408A JPH09504283A (ja) 1993-10-27 1994-10-26 ルフロキサシンおよびその塩の調製方法
ES94931550T ES2105780T3 (es) 1993-10-27 1994-10-26 Procedimiento para la preparacion de rufloxacina y sus sales.
AT94931550T ATE155788T1 (de) 1993-10-27 1994-10-26 Verfahren zur herstellung von rufloxacin und salze davon
EP94931550A EP0725785B1 (en) 1993-10-27 1994-10-26 Process for the preparation of rufloxacin and salts thereof
DK94931550.1T DK0725785T3 (da) 1993-10-27 1994-10-26 Fremgangsmåde til fremstilling af rufloxacin af deraf
PCT/EP1994/003512 WO1995011907A1 (en) 1993-10-27 1994-10-26 Process for the preparation of rufloxacin and salts thereof
US08/632,426 US5731433A (en) 1993-10-27 1994-10-26 Process for the preparation of rufloxacin and salts thereof
DE69404476T DE69404476T2 (de) 1993-10-27 1994-10-26 Verfahren zur herstellung von rufloxacin und salze davon

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI932286A IT1270836B (it) 1993-10-27 1993-10-27 Procedimento per la preparazione di rufloxacina e suoi sali

Publications (3)

Publication Number Publication Date
ITMI932286A0 ITMI932286A0 (it) 1993-10-27
ITMI932286A1 ITMI932286A1 (it) 1995-04-27
IT1270836B true IT1270836B (it) 1997-05-13

Family

ID=11367102

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI932286A IT1270836B (it) 1993-10-27 1993-10-27 Procedimento per la preparazione di rufloxacina e suoi sali

Country Status (9)

Country Link
US (1) US5731433A (it)
EP (1) EP0725785B1 (it)
JP (1) JPH09504283A (it)
AT (1) ATE155788T1 (it)
DE (1) DE69404476T2 (it)
DK (1) DK0725785T3 (it)
ES (1) ES2105780T3 (it)
IT (1) IT1270836B (it)
WO (1) WO1995011907A1 (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2467321A1 (en) * 2004-05-14 2005-11-14 Paul J. Santerre Polymeric coupling agents and pharmaceutically-active polymers made therefrom
JP7502186B2 (ja) 2018-02-02 2024-06-18 リップル セラピューティクス コーポレーション ステロイド二量体を含むガラス製剤およびその使用
US12473326B2 (en) 2019-02-01 2025-11-18 Ripple Therapeutics Corporation Crystalline forms of dexamethasone dimers and uses thereof
CN115956083A (zh) 2020-05-01 2023-04-11 波纹疗法公司 异二聚体组合物及用于治疗眼部病症的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3517709A1 (de) * 1985-01-05 1986-07-10 Bayer Ag Basische zubereitungen von chinoloncarbonsaeuren
JPH0228178A (ja) * 1988-04-23 1990-01-30 Toyama Chem Co Ltd 新規なピリドンカルボン酸誘導体およびその塩並びにそれらの製造法
IT1248011B (it) * 1991-06-07 1995-01-05 Mediolanum Farmaceutici Spa Procedimento per la preparazione dell'acido 9-fluoro-10- (4-metil-1-piperazinil)-7-oxo-2,3-diidro-7h-pirido (1,2,3-de) (1,4)benzotiadin-6-carbossilico cloridrato.

Also Published As

Publication number Publication date
DK0725785T3 (da) 1998-02-23
WO1995011907A1 (en) 1995-05-04
ATE155788T1 (de) 1997-08-15
EP0725785B1 (en) 1997-07-23
US5731433A (en) 1998-03-24
ITMI932286A0 (it) 1993-10-27
DE69404476T2 (de) 1997-12-04
JPH09504283A (ja) 1997-04-28
EP0725785A1 (en) 1996-08-14
ES2105780T3 (es) 1997-10-16
ITMI932286A1 (it) 1995-04-27
DE69404476D1 (de) 1997-09-04

Similar Documents

Publication Publication Date Title
ES2132415T3 (es) Nuevos derivados de 5-pirrolil-2-piridilmetilsulfinilbencimidazol.
NO985377L (no) FremgangsmÕte for Õ fremstille polyalkenaminer
DK0667856T3 (da) Nye D-vitaminanaloger
BR9408244A (pt) Derivados de azabiciclo[3.2.0]heptano N-substituídos
HUT65876A (en) Process for producing antiretroviral tripeptide derivatives
IT1270836B (it) Procedimento per la preparazione di rufloxacina e suoi sali
DE69103087D1 (de) N-substituierte Trifluormethylphenyltetrahydropyridine, Verfahren zur Herstellung, Zwischenprodukte, sowie Arzneimittel, die solche enthalten.
GR3021736T3 (en) N-substitued 3-azabicyclo 3.2.0]heptane derivatives useful as neuroleptic agents etc.
RO91140A (ro) Procedeu pentru prepararea unor saruri de piridiniu
HUT57720A (en) Process for producing indole derivatives and pharmaceutical compositions comprising such compounds
MX9306995A (es) Derivados de acido orto-etenilfenilacetico sustituidos.
DK0660819T3 (da) Nye N,N,N,N-tetrasubstituerede 1,2-ethandiaminderivatforbindelser
AU7625096A (en) Production of a salt of clavulanic acid
IE822853L (en) 1-piperazino carboxylates
ES2106104T3 (es) Procedimiento para la sintesis enantioselectiva de derivados de monoamida de acido 2(r)-bencilsuccinico.
HU9600300D0 (en) Thiocarbamoyl derivatives using as antimicrobial agents and process for producing of these
ZA95934B (en) Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
ES2140683T3 (es) Procedimiento para preparar compuestos de benzopirano.
PT99378A (pt) Processo para a preparacao de intermediarios uteis para a preparacao de acido 4,5-difluoroantranilico
IT1254201B (it) Procedimento per la preparazione di derivati del glicerolo otticamente attivi.
RU94046014A (ru) Диаминовые соли клавулановой кислоты

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971030